Table 2 Fasting plasma concentrations of glucose, insulin and C-peptide at baseline in participants receiving a single dose of glucose or ENSO 16.

From: The substitute ENSO 16 has low impact on glucose metabolism in healthy humans: a randomized, double-blind, active-controlled, cross-over trial

 

Glucose

ENSO 16

p values

Glucose [mg*dL−1]

79 ± 9

80 ± 6

0.5069

Insulin [µIU*mL−1]

6.36 ± 2.09

6.59 ± 2.08

0.676

C-peptide [ng*dL−1]

1.78 ± 0.69

1.67 ± 0.35

0.4593

  1. Results are mean ± SD, n = 15 per treatment. Differences in laboratory values were not significant between treatments at baseline (Student’s paired t-test).
Back to article page